State Department Reveals 2009 Intelligence Budget Request
The U.S. State Department’s Bureau of Intelligence and Research (INR) is among the most highly regarded members of the U.S. Intelligence Community. Not coincidentally, it is also among the most open and accessible.
In particular, it is one of the only Intelligence Community organizations that regularly publishes its budget (pdf). (The FBI also discloses much of its intelligence spending.)
Thus, the recent 2009 State Department budget justification book projects a 2009 INR budget of $59.8 million for a staff of 313 persons.
This would be unremarkable except for the fact that INR’s budget disclosure policy deviates from the norm of U.S. intelligence classification policy, in which most budget information is automatically classified. Even some intelligence organizations that are smaller and less influential than INR insist on classifying their budgets.
For more than a decade, the Department of Energy Office of Intelligence published its detailed budget each year. But under pressure from CIA (so I was told), DOE began withholding its intelligence budget information in 2004. The last reported figure for DOE intelligence was $39.8 million in FY 2004.
If consistency in classification policy were to prevail throughout the U.S. intelligence community, as the Director of National Intelligence has recommended, then State Department intelligence might be expected to follow DOE intelligence into pointless, unnecessary secrecy.
The transition to a clean energy future and diversified sources of energy requires a fundamental shift in how we produce and consume energy across all sectors of the U.S. economy.
A deeper understanding of methane could help scientists better address these impacts – including potentially through methane removal.
While it is reasonable for governments to keep the most sensitive aspects of nuclear policies secret, the rights of their citizens to have access to general knowledge about these issues is equally valid so they may know about the consequences to themselves and their country.
Advancing the U.S. leadership in emerging biotechnology is a strategic imperative, one that will shape regional development within the U.S., economic competitiveness abroad, and our national security for decades to come.